MRSA 檢測市場規模、佔有率及成長分析（按產品類型、檢測類型、最終用戶和地區）—產業預測，2025 年至 2032 年

2023 年全球 MRSA 檢測市場規模價值為 45 億美元，預計將從 2024 年的 46.8 億美元成長到 2032 年的 64.6 億美元，預測期內（2025-2032 年）的複合年成長率為 4.1%。

全球 MRSA 檢測市場正在經歷顯著成長，這得益於醫療保健系統對抗生素抗藥性感染疾病的快速檢測的迫切需求。抗藥性金黃色葡萄球菌(MRSA) 仍然是一個主要的公共衛生問題，尤其是在醫院環境中。隨著 MRSA 感染的盛行率上升，對準確及時的診斷測試的需求也在增加。各種醫療機構對感染控制的重視程度不斷提高，以及旨在遏制疫情爆發的照護現場和分子診斷技術的應用日益廣泛，是市場擴張的主要驅動力。自動化平台和基於 PCR 的檢測方法的進步提高了檢測能力，改善了臨床結果。此外，強制性篩檢指南和人們對抗菌素抗藥性日益成長的認知，正在鼓勵診斷公司提供具有成本效益的解決方案，進一步將 MRSA 檢測納入全球感染控制策略。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析

MRSA 檢測市場規模（依產品類型分類）及複合年成長率（2025-2032）

• 市場概覽
• 裝置
• 試劑和套件

MRSA 檢測市場規模（依檢測類型分類）及複合年成長率（2025-2032）

• 市場概覽
• 免疫診斷測試
• 分子診斷檢測

MRSA 檢測市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 診斷實驗室
• 學術研究所

MRSA 檢測市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• 3M Co.
• Abbott Laboratories
• ALIFAX Srl
• Arlington Scientific Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Creative Diagnostics
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.
• R Biopharm AG
• Sekisui Diagnostics LLC
• Uniogen Oy
• ZeptoMetrix LLC

結論和建議

Global MRSA Testing Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.68 billion in 2024 to USD 6.46 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The global MRSA testing market is witnessing significant growth, driven by healthcare systems' urgent need for rapid detection of antibiotic-resistant infections. Methicillin-resistant Staphylococcus aureus (MRSA) remains a major public health concern, particularly in hospital settings. As the prevalence of MRSA infections rises, so does the demand for accurate and timely diagnostic tests. The focus on infection control in various healthcare facilities is a key factor fueling market expansion, along with the increasing adoption of point-of-care and molecular diagnostic technologies aimed at curbing outbreaks. Advancements in automated platforms and PCR-based assays are enhancing detection capabilities, thus improving clinical outcomes. Additionally, mandatory screening guidelines and heightened awareness of antimicrobial resistance are pushing diagnostic companies to offer cost-effective solutions, further embedding MRSA testing into global infection control strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRSA Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRSA Testing Market Segments Analysis

Global MRSA Testing Market is segmented by Product Type, Test Type, End user and region. Based on Product Type, the market is segmented into Instruments and Reagents & Kits. Based on Test Type, the market is segmented into Immunodiagnostic Test and Molecular Diagnostic Test. Based on End user, the market is segmented into Hospitals, Diagnostic Laboratories and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MRSA Testing Market

The increasing prevalence of antibiotic-resistant bacteria, particularly MRSA and VRSA, is driving a surge in hospital-acquired infections, notably in high-risk environments like intensive care units and dialysis facilities. Contributing factors include prolonged hospitalizations and the use of invasive medical procedures. This alarming trend underscores the urgent necessity for enhanced infection control strategies, as evidenced by concerning rates of MRSA colonization documented by health organizations such as the CDC and NHS. Consequently, the global MRSA testing market is expanding to address these critical healthcare challenges and improve patient outcomes through more effective diagnostic and treatment options.

Restraints in the Global MRSA Testing Market

The Global MRSA Testing market faces challenges primarily related to patient safety, particularly for vulnerable populations that rely heavily on healthcare services. The transmission of MRSA primarily occurs through direct contact and the use of medical devices. Additionally, contamination issues extend beyond traditional healthcare settings, impacting industries such as telecommunications and electronics, especially during the surface mount technology (SMT) and printed circuit board (PCB) assembly processes. This highlights a pressing need for effective infection prevention measures across various sectors, emphasizing that MRSA concerns are not limited to healthcare environments alone. Addressing these challenges is crucial for overall safety and risk management.

Market Trends of the Global MRSA Testing Market

The Global MRSA Testing market is experiencing a significant trend towards the adoption of AI-powered diagnostic platforms, transforming traditional testing methodologies. These innovative tools enhance diagnostic workflows by automating result interpretation, expediting image analysis, and improving detection accuracy, ultimately fostering better patient outcomes. With the implementation of AI, laboratories can achieve quicker turnaround times and heightened operational efficiency, which is crucial in high-risk healthcare environments. This technological advancement not only streamlines the testing process but also empowers healthcare professionals to implement timely infection control interventions, reflecting a paradigm shift in MRSA management and detection strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global MRSA Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits

Global MRSA Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Immunodiagnostic Test
• Molecular Diagnostic Test

Global MRSA Testing Market Size by End user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Global MRSA Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Test Type, End user)
  • US
  • Canada
• Europe (Product Type, Test Type, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALIFAX Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arlington Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSPEED Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uniogen Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations